万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>胃肠肝病学

Gastroenterología y Hepatología(或:GASTROENTEROLOGIA Y HEPATOLOGIA)《胃肠病学和肝病学》 (官网投稿)

简介
  • 期刊简称GASTROENT HEPAT-BARC
  • 参考译名《胃肠病学和肝病学》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率4.90%
  • 主要研究方向医学-GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学

主要研究方向:

等待设置主要研究方向
医学-GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学

Gastroenterología y Hepatología《胃肠病学和肝病学》(一年10期). The mission of Gastroenterología y Hepatología is to cover a broad spectrum of themes ...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2期刊网址:

https://www.journals.elsevier.com/gastroenterologia-y-hepatologia

3投稿网址:

https://www.editorialmanager.com/gastrohepato/

4期刊刊期:双月刊,一年出版6

2021年8月6日星期

                                 

 

投稿须知【官网信息】

 

Guide for Authors

The mission of Gastroenterología y Hepatología is to cover a broad spectrum related with gastroenterology and hepatology, including the latest advances in pathology of the gastrointestinal tract, inflammatory bowel disease, liver, pancreas and bile ducts, making it an indispensable tool for gastroenterologists, hepatologists, internists and general practitioners, offering in-depth reviews and updates on issues relating to the specialty. In addition to the rigorously selected, systematically peer-reviewed manuscripts published in the research sections (research articles, scientific letters, editorials, and letters to the editor), the journal also publish consensus documents and clinical guides from the most prominent scientific societies. The publication is the official journal of the Spanish Association of Gastroenterology (AEG), the Spanish Association for the Study of the Liver (AEEH), and the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU). The journal is included in Medline/Pubmed, Science Citation Index Expanded and SCOPUS.

Types of article

For any section of this journal, except letters to the editor, the three epigraphs:

Ethical considerations,Funding and Conflict of interestshould be added at Essential title page information.

Ethical considerations: If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans; Uniform Requirements for manuscripts submitted to Biomedical journals. Authors should include a statement that informed consent was obtained for experimentation with human subjects, and all the ethical procedures were performed. The privacy rights of human subjects must always be observed. Theapproval of the institutional review board (IRB)or the appropriate committee must be stated in this epigraph.

Funding: You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Conflict of interest: All authors must disclose any financial and personal relationships with other people or organizations that could influence (bias) their work,even if it is not directly related to the current manuscript. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding, as well as travel grants and participation in courses and conferences as a paid expert. If there are no interests to declare then please state this: 'Declarations of interest: none'.

ORIGINAL ARTICLES

Original research about etiology, physiopathology, pathology, epidemiology, clinical aspects, diagnosis, prognosis and treatment of the digestive diseases are recommended for this section. Analytic studies like transversal surveys, case-controls studies, cohort studies and randomized controlled trials prioritzing multicenter studies, will be preferentially considered for publication. The article must have the following headings: Introduction; Patients and Methods; Results; and Discussion. The text is limited to a maximum of 4,000 words, not including references, abstract and figure legends. The abstract is limited to a maximum of 250 words and need to be structured. There should be no more than 30 references. The total combined number of tables and figures should not exceed 6. In the revised version by the authors, a graphical/visual abstract will have to be included compulsorily in the revised manuscript version, which will be published along with the manuscript. See below specific instructions to elaborate the graphical/visual abstract.

REVIEW ARTICLES

Reviews of current work reflecting progress in various fields of medicine are requested from recognized specialists. Voluntary contributions will be subject to consideration by the Editorial Board. The text is limited to 4,000 words not including abstract, figure legends, and references. The abstract is limited to a maximum of 150 words and does not need to be structured. Up to 6 figures or tables will be accepted. References are limited to a maximum of 60. Up to 5 authors are accepted.

SPECIAL ARTICLES

Articles reflecting original opinions and interpretation of relevant topics, narrative and practical reviews are included in this section. Voluntary contributions will be subject to consideration by the Editorial Board. The text is limited to 4,000 words. Up to 4-5 figures or tables will be accepted. References are limited to a maximum of 30. Up to 4 authors are accepted.

CONSENSUS AND GUIDELINES STATEMENTS

Consensus documents and clinical practice guidelines must be promoted and endorsed by at least two scientific Societies, or promoted by health authorities. Authors are required to attach a letter arguing its importance to the clinical community. The consensus documents and clinical guidelines will be based on a recent systematic search, reported according to PRISMA-S 1. The analysis of the degree of evidence of the publications found will be based on guidelines such as AGREE-II 2 or GRADE 3. In case of not being able to provide first-level evidence, the authors: (1) will highlight the convenience of covering this scientific gap; and (2) explain the method used to reach consensus. 1 Systematic Reviews (2021) 10:39 https://doi.org/10.1186/s13643-020-01542-z 2 https://www.agreetrust.org/wp-content/uploads/2013/06/AGREE_II_Spanish.pdf 3 GRADE system: classification of the quality of the evidence and grading of the strength of the recommendation. DOI: 10.1016 / j.ciresp.2013.08.002 The journal will not accept to publish any Consensus Document or Clinical Guide that does not have the Funding and Conflict of interestssections of all authors perfectly detailed and completed.

EDITORIALS

They are always commissioned, although unsolicited editorials may occasionally be considered previous consultation with the Editor. The text is limited to a maximum of 2,000 words, tables and figures are not allowed. There should be no more than 20 references. Up to 2 authors are accepted. SCIENTIFIC LETTERS

Letters containing original investigation with small number of cases and with an specific conclusion are the first choice for this section. Letters should contain fewer than 700 words, one table or figure and must contain no more than 5 references.

LETTERS TO THE EDITOR

Letters related to articles published by the journal are the first choice for this section as well as letters providing opinions and observations foused in a topic of current interest. The letters related with published articles must be received within three weeks after the publication of the article and at the discretion of the Editorial Board will be sent to the author of the article, who will have 4 weeks in which to answer. Letters should contain fewer than 700 words, one table or figure, and must contain no more than 5 references. After publication of the reply, no further correspondence will be accepted. Up to 4 authors are accepted. IMAGES OF THE MONTH

Images (clinical, endoscopic, radiography, microbiological, pathological) focused encouraging the challenge of the readers are suitable for this section. Images with visual remarks for learning will be prioritized. Only high quality images will be accepted. The text is limited to a maximum of 200 words. Graphics resources (arrows, asterisk, etc..) can be mandatory for visual remarks.

Contact details for submission

You can send your manuscript at https://www.editorialmanager.com/gastrohepato/default.aspx/

Language

This journal is published in Spanish and in English language.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present: One author has been designated as the corresponding author with contact details:

E-mail address Full postal address

All necessary files have been uploaded: Manuscript:

Include keywords

All figures (include relevant captions)

All tables (including titles, description, footnotes)

Ensure all figure and table citations in the text match the files provided

Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable) Supplemental files (where applicable) Further considerations

Manuscript has been 'spell checked' and 'grammar checked'

All references mentioned in the Reference List are cited in the text, and vice versa

Permission has been obtained for use of copyrighted material from other sources (including the Internet)

A competing interests statement is provided, even if the authors haveA no competing interests to declare

Journal policies detailed in this guide have been reviewed

Referee suggestions and contact details provided, based on journal requirements

Ethics in publishing

Please see our information on Ethics in publishing.

Studies in humans and animals

If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.

Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.

Informed consent and patient details

Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

……

更多详情:

https://www.elsevier.com/journals/gastroenterologia-y-hepatologia/0210-5705/guide-for-authors


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭